|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 | |
| A61P 35/00 |
| (11) | Patento numeris | 2365828 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 09825523.5 |
| Europos patento paraiškos padavimo data | 2009-11-06 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-09-21 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-10-15 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2009/063647 |
| Data | 2009-11-06 |
| (87) | Numeris | WO 2010/054265 |
| Data | 2010-05-14 |
| (30) | Numeris | Data | Šalis |
| 112686 P | 2008-11-07 | US | |
| 164870 P | 2009-03-30 | US |
| (72) |
KIM, Kyung Jin, US
ZHAO, Wei-Meng, US
PARK, Hangil, US
VASQUEZ, Maximiliano, US
|
| (73) |
Galaxy Biotech, LLC,
22830 San Juan Road, Cupertino, CA 95014,
US
|
| (54) | MONOCLONAL ANTIBODIES TO FIBROBLAST GROWTH FACTOR RECEPTOR 2 |
| MONOCLONAL ANTIBODIES TO FIBROBLAST GROWTH FACTOR RECEPTOR 2 |